A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Ultrasound-guided Transthoracic Intramyocardial Injection in Mice

14.9K views

⸱

DOI:

10.3791/51566

⸱

August 5th, 2014

 ,  ,  ,  ,  , 

In This Article

Summary

Echocardiography-guided percutaneous intramyocardial injection represents an efficient, reliable, and targetable modality for the delivery of gene transfer agents or cells into the murine heart. Following the steps outlined in this protocol, the operator can quickly become competent in this versatile, minimally invasive technique.

Abstract

Murine models of cardiovascular disease are important for investigating pathophysiological mechanisms and exploring potential regenerative therapies. Experiments involving myocardial injection are currently performed by direct surgical access through a thoracotomy. While convenient when performed at the time of another experimental manipulation such as coronary artery ligation, the need for an invasive procedure for intramyocardial delivery limits potential experimental designs. With ever improving ultrasound resolution and advanced noninvasive imaging modalities, it is now feasible to routinely perform ultrasound-guided, percutaneous intramyocardial injection. This modality efficiently and reliably delivers agents to a targeted region of myocardium. Advantages of this technique include the avoidance of surgical morbidity, the facility to target regions of myocardium selectively under ultrasound guidance, and the opportunity to deliver injectate to the myocardium at multiple, predetermined time intervals. With practiced technique, complications from intramyocardial injection are rare, and mice quickly return to normal activity on recovery from anesthetic. Following the steps outlined in this protocol, the operator with basic echocardiography experience can quickly become competent in this versatile, minimally invasive technique.

Introduction

Heart disease is the leading cause of death for both men and women in the United States, accounting for 600,000 deaths annually1. Murine models of cardiovascular disease are critically important for investigating pathophysiological mechanisms and for exploring potential therapies. Myocardial delivery of gene therapy vectors, stem cells, modified RNAs, and other therapeutic agents permits investigation of their therapeutic potential for heart disease2-7. Currently, there are limited options for myocardial delivery of therapeutic agents in mouse models6. Intramyocardial injection under direct visualization is commonly used, but requires ....

Access restricted. Please log in or start a trial to view this content.

Protocol

All described steps were performed under protocols approved by the Institutional Animal Care and Use Committee of Boston Children’s Hospital.

1. Preparation

  1. Perform baseline cardiac anatomical and functional assessment by echocardiography prior to beginning the injection protocol, as the optimal fixed transducer position for intramyocardial injection may not yield the optimal standard views for delineating anatomy and assessment of function.
  2. The injection setup is shown in Figures 1A-1C. Place an empty syringe with a sheathed needle, bevel oriented upwards, in the syringe clamp (see Figur....

Access restricted. Please log in or start a trial to view this content.

Results

Murine Intramyocardial Injection with Blue Dye or Fluorescent Microspheres

Injection of Evan’s blue dye is useful for training purposes. Soon after injection, euthanize the mouse and remove the heart to visualize the location of the injected blue dye. Figure 5 shows an example of a successful injection, with blue dye infiltrating the myocardium at the mid-papillary muscle level (Figure 5A, region enclosed by dotted line). Evans blue dye will wash out of the tissu.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Biologics can be delivered to the myocardium by direct intramyocardial injection, intrapericardial injection, or indirect administration via the bloodstream. Recent cell based therapy trials in myocardial infarction models have described an open thoracotomy approach to the delivery of injectate12-14. An important factor in the success of a myocardial therapeutic intervention hinges on the choice of delivery route. The highest local dose of biologic is achieved by intramyocardial delivery15,16. Intra.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

TWP was funded by the Irish Cardiac Society Brian McGovern Travelling Fellowship. WTP was funded by R01 HL095712 and an AHA Established Investigator Award.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Vevo 2100 ultrasound imaging system Visualsonics
Vevo Integrated Rail System IIIVisualsonics
Microscan MS400 transducerVisualsonics
Microscan MS550D transducerVisualsonics
PrecisionGlide needlesBD30512830 G x 1 in/2.5 cm
1 cc slip tip syringeExel International 26048or equivalent
Gastight 50 μl glass syringesHamilton1705
Trypan blue stain (0.4%)Gibco 15250or equivalent
IsofluraneBaxterAHN3640or equivalent
Aquasonic 100Parker Laboratories(01-08)or equivalent
Polystyrene microspheres (red fluorescent)Life TechnologiesF-8842or equivalent

References

  1. Kochanek, K. D., et al. Deaths: final data for 2009. Natl Vital Stat Rep. 60 (3), 1-117 Forthcoming.
  2. Strauer, B. E., Steinhoff, G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: fro....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Ultrasound-guided InjectionMyocardial InjectionTransthoracic InjectionMouse ModelEchocardiography GuidanceNeedle AlignmentTissue Marker DeliveryCross-sectional MicroscopyAdenovirus InjectionCardiac Anatomy Assessment